Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
IglooFlow AB
AB
Active
Org 5595299990
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2025 · 1 year old
0 employees
Monitor
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
IglooFlow AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
0M
-1M
-1M
2025: 0M
0M
2025
EBITDA
SEK millions
0M
0M
0M
-1M
-1M
2025: 0M
0M
2025
Income statement
SEK thousands
Item
2025
Revenue
0
Staff expenses
—
EBITDA
−38
Depreciation & amort.
—
EBIT
−38
Net financials
—
Profit before tax
−38
Tax
—
Net profit
−38
Balance sheet
SEK thousands
Item
2025
Total assets
48
Equity
−13
Long-term debt
—
Short-term debt
61
Total debt
61
Financial ratios
5-year trend
EBITDA margin
<−999 %
This company
15,8 %
Market median
This company
Market median
>999% below market
2025
2025
Equity ratio
−26,2 %
This company
38,2 %
Market median
This company
Market median
169% below market
2025
2025
Return on equity
—
This company
18,4 %
Market median
This company
Market median
2025
2025
Net profit margin
<−999 %
This company
8,1 %
Market median
This company
Market median
>999% below market
2025
2025
Asset turnover
0,00×
This company
1,12×
Market median
This company
Market median
100% below market
2025
2025
Debt / equity
—
This company
0,62×
Market median
This company
Market median
2025
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-05-06 – 2025-12-31
View
PDF
More on IglooFlow AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
